Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content type

Project (76)
Report Summary (38)

Country

Argentina (1)
Austria (5)
Belgium (8)
Croatia (1)
Czech Republic (3)
Denmark (9)
Estonia (5)
Finland (4)
France (19)
Germany (27)
Greece (1)
Iceland (2)
Ireland (5)
Israel (5)
Italy (14)
Latvia (2)
Malta (2)
Netherlands (17)
New Caledonia (1)
Norway (7)
Poland (5)
Portugal (9)
Romania (2)
Russia (1)
Slovakia (1)
Slovenia (5)
Spain (25)
Sweden (8)
Switzerland (8)
Turkey (2)
United Kingdom (19)

Advanced search

Search projects and results

Results 1 - 10 of 114
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Periodic Reporting for period 1 - CanPathPro (Generation of the CanPath prototype - a platform for predictive cancer pathway modeling)
Cancer is the result of mutations in multiple genes, which give rise to the disease’s enormous molecular complexity affecting multiple signalling pathways and their cross talk. An influx of tumour “omics” data (genomic, transcriptomic, proteomic) has allowed the...
Programme: H2020-EU.2.1.4.
Record Number: 202051
Last updated on: 2017-08-04
Periodic Reporting for period 1 - EmPowerPutida (Exploiting native endowments by re-factoring, re-programming and implementing novel control loops in Pseudomonas putida for bespoke biocatalysis)
Synthetic Biology (SynBio) is bound to be transformative in Industrial and Environmental Biotechnology. The powerful methodologies for high-throughput genome engineering, model-driven design and circuit construction, along with new concepts for bioprocess engineering enable...
Programme: H2020-EU.2.1.4.
Record Number: 198419
Last updated on: 2017-05-19
Periodic Reporting for period 1 - FLUSENSOR (FLUSENSOR - innovative, ultra-sensitive, fast and cheap micro-test to detect influenza virus)
Seasonal and pandemic influenza pose ongoing risks to global human public health. The emergence of the novel influenza A(H1N1) 2009 virus in the human population has led to a global influenza pandemic. Influenza diagnostic tests which aid in case management and outbreak...
Programme: H2020-EU.2.1.4.
Record Number: 196293
Last updated on: 2017-03-28
Periodic Reporting for period 1 - SOS Jelly (An advanced biological remedy against jellyfish stings)
The project SOSJelly intends to evaluate the feasibility of the development, manufacturing method, technological transfer and industrial scale-up and to third parties’ manufacturers, and licensing for commercialization of a completely new biosynthetic molecule or mix of...
Programme: H2020-EU.2.1.4.
Record Number: 196447
Last updated on: 2017-03-30
Periodic Reporting for period 1 - SYNBIOMAN (Demonstration of a synthetic biology-driven biomanufacturing platform for adaptable cost-effective production of high-value low volume biologics opportunities.)
Problem addressed: Ingenza’s SYNBIOMAN platform will address an unmet industry need at the European level for a synthetic biology enabled therapeutic biologics manufacturing capability targeting difficult-to-express proteins and/or hard-to-handle potent protein products that...
Programme: H2020-EU.2.1.4.
Record Number: 196392
Last updated on: 2017-03-29
Periodic Reporting for period 1 - ROBOX (Expanding the industrial use of Robust Oxidative Biocatalysts for the conversion and production of alcohols (ROBOX))
Oxygen functionalities are key functional groups in many chemicals and materials. The efficient introduction of oxygen-functionalities into raw materials are key chemical transformations in bulk and fine chemicals. Innovative biocatalytic oxidation routes using molecular...
Programme: H2020-EU.2.1.4.
Record Number: 195227
Last updated on: 2017-02-23
Periodic Reporting for period 1 - DiViNe (Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes)
In the vaccine industry, downstream processing is of extreme importance. Prophylactic vaccines aim at protecting healthy people, so any contaminant has to be removed with the most drastic measures. Such « negative » approach comes at the expense of the recovery of product:...
Programme: H2020-EU.2.1.4.
Record Number: 194893
Last updated on: 2017-02-16
Periodic Reporting for period 1 - FACTs (Fast Acting Virus Control Strategies for Production Animal Diseases)
ViroVet was the operating name of Aratana Therapeutics’ livestock team. The strategic business plan that resulted from FACTs led to ViroVet’s incorporation as a dedicated, disruptive biotech company (30 July 2015). ViroVet will focus on the introduction of a product for...
Programme: H2020-EU.2.1.4.
Record Number: 186126
Last updated on: 2016-07-07
Periodic Reporting for period 1 - FGFSTAB (Industrial Production of Stable Fibroblast Growth Factors for Broad Therapeutic, Research, and Personal Care Applications)
Enantis, a biotechnology company working in the field of protein engineering and enzyme technologies, was founded in 2006 as the first biotech spin-off of the Masaryk University in Brno (Czech Republic). The company has proprietary protein stabilization technology which is...
Programme: H2020-EU.2.1.4.
Record Number: 186054
Last updated on: 2016-07-06
Periodic Reporting for period 2 - H2AD-aFDPI (H2AD - Innovative and scalable biotechnology using Microbial Fuel Cell and Anaerobic Digestion for the treatment of micro-scale industrial and agriculture effluents to recover energy from waste)
Catalysed by their activities as mechanical engineers to the UK water treatment, energy & manufacturing industries, Lindhurst Innovation Engineering (LIE) have developed H2AD - a novel micro-scale technology for the rapid & safe disposal of organic effluents. H2AD uses an...
Programme: H2020-EU.2.1.4.
Record Number: 190102
Last updated on: 2016-11-07
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-09-26
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top